

Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|14|3|169-181
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.14, Iss.3, 2014-09, pp. : 169-181
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives
Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. :


Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives
Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. :


By Montemurro Filippo Rossi Valentina Geuna Elena Valabrega Giorgio Martinello Rossella Milani Andrea Aglietta Massimo
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. :